PMID: 9541091Apr 16, 1998Paper

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

Lupus
E TsakonasC D Smith

Abstract

The ability of antimalarials to moderate severe disease activity in systemic lupus erythematosus (SLE) is plausible but undemonstrated. We evaluated the long-term effectiveness of maintaining treatment with hydroxychloroquine sulphate (HCQ) to prevent major flares in quiescent SLE. Forty-seven patients with quiescent SLE who had been randomized to take HCQ (n = 25) or placebo (n = 22) as part of a 24-week withdrawal trial were evaluated for an additional 3 years. The primary outcome was time to a major flare of SLE which resulted in either the institution of or an increase in the current dosage of prednisone of 10 mg/day or more, or institution of therapy with immunosuppressive agents. Secondary outcomes included the specific subtype of these major flares (glomerulonephritis, vasculitis or other) and hospitalization for an exacerbation of SLE. An intent-to-treat analysis was conducted. Over the 42 months of study, 11 of 22 (50%) patients randomized initially to placebo, and seven of 25 (28%) patients randomized to continue treatment experienced a major flare. The relative risk of major flare for those randomized to continue HCQ compared with controls was 0.43 (95% CI: 0.17, 1.12). The relative risks for subtypes of flares were ...Continue Reading

References

Aug 1, 1978·Seminars in Arthritis and Rheumatism·E L Dubois
Jan 17, 1991·The New England Journal of Medicine·UNKNOWN Canadian Hydroxychloroquine Study Group
Jun 1, 1985·Clinical Pediatrics·R A Feinstein, M V Miles
Jan 1, 1985·Journal of Chronic Diseases·O S Miettinen
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Feb 1, 1980·Arthritis and Rheumatism·R F MeenanJ H Mason
Oct 1, 1994·Controlled Clinical Trials·M Borenstein
Aug 1, 1958·Arthritis and Rheumatism·M ZIFFC McEWEN

❮ Previous
Next ❯

Citations

Apr 9, 2009·Rheumatology International·Samuel Katsuyuki Shinjo
Nov 15, 2007·Zeitschrift für Rheumatologie·R Fischer-Betz, M Schneider
Dec 17, 2008·Zeitschrift für Rheumatologie·R Fischer-Betz, M Schneider
Nov 7, 2008·Clinical Rheumatology·Stephanie O Keeling, Anna E Oswald
May 16, 2012·Modern Rheumatology·Antonis FanouriakisDimitrios T Boumpas
Jan 12, 2011·Clinical Reviews in Allergy & Immunology·Ilan Ben-ZviYehuda Shoenfeld
Jun 16, 2001·International Immunopharmacology·M MoscaG R Hughes
Oct 20, 2011·Nature Reviews. Nephrology·Senq-J LeeJoanne M Bargman
Jan 5, 2010·Nature Reviews. Rheumatology·Thomas Dörner
Sep 30, 1999·Current Opinion in Rheumatology·E B Brooks, M H Liang
Jan 19, 2013·Current Opinion in Nephrology and Hypertension·Jonathan Hogan, Gerald B Appel
Nov 14, 2007·International Journal of Clinical Practice·J Ermann, B L Bermas
Aug 2, 2012·Annals of the Rheumatic Diseases·George K BertsiasUNKNOWN European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association
Dec 20, 2012·Therapeutic Advances in Chronic Disease·Susan S KimDoruk Erkan
Oct 24, 2009·Arthritis Research & Therapy·Mary K Crow
Mar 11, 2006·Medicinski pregled·Gordana RadekaIgor Mitić
Mar 27, 2012·International Journal of Clinical Rheumatology·Erica F Lawson, Jinoos Yazdany
Apr 18, 2014·Annals of the Rheumatic Diseases·Ronald F van VollenhovenMatthias Schneider
May 24, 2014·La Presse médicale·Nathalie Costedoat-ChalumeauGaëlle Guettrot-Imbert
Nov 6, 2013·Clinical and Experimental Rheumatology·Marta Mosca, Ronald van Vollenhoven
May 18, 2011·Current Rheumatology Reports·Maria Dall'era, Eliza F Chakravarty
Oct 20, 2015·Expert Opinion on Pharmacotherapy·M W P Tsang-A-Sjoe, I E M Bultink
Jan 24, 2013·Expert Opinion on Biological Therapy·Zahi ToumaDafna D Gladman
Jun 1, 2012·Kidney International Supplements
Apr 10, 2012·Micron : the International Research and Review Journal for Microscopy·Anthony S QuinnDouglas J Taatjes
Jul 10, 2007·La Revue de médecine interne·N Costedoat-ChalumeauJ-C Piette
Apr 6, 2005·Clinical and Experimental Immunology·F Goldblatt, D A Isenberg
May 30, 2009·Arthritis and Rheumatism·Guillermo J Pons-EstelUNKNOWN Lumina Study Group
Jun 12, 2013·Arthritis and Rheumatism·Michelle A PetriUNKNOWN BLISS-52 and BLISS-76 Study Groups
Apr 15, 2010·Arthritis Care & Research·Gabriela SchmajukEdward Yelin
Aug 30, 2011·American Journal of Obstetrics and Gynecology·Xiao-Xuan WuJacob H Rand
Oct 24, 2014·Rheumatology·Nuntana KasitanonWorawit Louthrenoo
Mar 13, 2015·Current Rheumatology Reports·Zehra Serap ArıcıSeza Ozen
Nov 26, 2014·Nature Reviews. Nephrology·Tak Mao Chan
Mar 14, 2016·Paediatric Drugs·Colin ThorbinsonMichael W Beresford
Nov 12, 2015·Arthritis Care & Research·Martin Michaud, Francis Gaches
Aug 1, 2016·Clinical Rheumatology·Juan Manuel Mejía-ViletRicardo Correa-Rotter
Dec 18, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bhadran BoseJoanne M Bargman
Sep 13, 2006·Clinics in Dermatology·J Andrew CarlsonJane M Grant-Kels
Sep 18, 2012·Autoimmunity Reviews·Andrea T BorchersM Eric Gershwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.